Original Article
Black Cohosh Hepatic Safety: Follow-Up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature
Table 3
Follow up of five patients suffering from stable chronic liver disease.
| Patients at baseline and control | 1 Baseline | 1 Control | 2 Baseline | 2 Control | 3 Baseline | 3 Control | 4 Baseline | 4 Control | 5 Baseline | 5 Control |
| Leukocyte | 5780 mm3 | 6300 mm3 | 3990 mm3 | 4100 mm3 | 6700 mm3 | 6900 mm3 | 8000 mm3 | 7450 mm3 | 3450 mm3 | 4500 mm3 | Tot bilirubin | 1.4 mg dl−1 | 1.3 mg dl−1 | 0.9 mg dl−1 | 0.9 mg dl−1 | 0.7 mg dl−1 | 0.6 mg dl−1 | 0.2 mg dl−1 | 0.3 mg dl−1 | 0.4 mg dl−1 | 0.5 mg dl−1 | AST | 57 IU l−1 | 67 IU l−1 | 38 IU l−1 | 39 IU l−1 | 45 IU l−1 | 46 IU l−1 | 38 IU l−1 | 42 IU l−1 | 41 IU l−1 | 33 IU l−1 | ALT | 47 IU l−1 | 52 IU l−1 | 36 IU l−1 | 33 IU l−1 | 37 IU l−1 | 35 IU l−1 | 20 IU l−1 | 18 IU l−1 | 45 IU l−1 | 42 IU l−1 | Alkaline phosphatase | 150 U l−1 | 156 U l−1 | 119 U l−1 | 118 U l−1 | 110 U l−1 | 105 U l−1 | 120 U l−1 | 122 U l−1 | 110 U l−1 | 80 U l−1 | γGT | 55 U l−1 | 59 U l−1 | 22 U l−1 | 25 U l−1 | 35 U l−1 | 32 U l−1 | 45 U l−1 | 44 U l−1 | 48 U l−1 | 35 U l−1 | Albumin | 3.5 g dl−1 | 3.6 g dl−1 | 4.1 g dl−1 | 4.2 g dl−1 | 3 g dl−1 | 2.9 g dl−1 | 3.8 g dl−1 | 4 g dl−1 | 4.2 g dl−1 | 4.4 g dl−1 | INR | 0.8 | 0.9 | 1.2 | 1.3 | 0.9 | 0.9 | 1.1 | 1.1 | 1 | 1.2 |
|
|